Cite
Early ultrasound evaluation identifies excellent responders to neoadjuvant systemic therapy among patients with triple‐negative breast cancer
MLA
Peng Wei, et al. “Early Ultrasound Evaluation Identifies Excellent Responders to Neoadjuvant Systemic Therapy among Patients with Triple‐negative Breast Cancer.” Cancer, vol. 127, Apr. 2021, pp. 2880–87. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....43b248fd85f93cc33db8890223ada0e8&authtype=sso&custid=ns315887.
APA
Peng Wei, Wei T. Yang, Lumarie Santiago, Marion E. Scoggins, Rosalind P. Candelaria, Alastair M. Thompson, Gary J. Whitman, Beatriz E. Adrada, Tanya W. Moseley, Jason B White, Vicente Valero, Stacy L. Moulder, Elizabeth Ravenberg, Jennifer K. Litton, & Gaiane M. Rauch. (2021). Early ultrasound evaluation identifies excellent responders to neoadjuvant systemic therapy among patients with triple‐negative breast cancer. Cancer, 127, 2880–2887.
Chicago
Peng Wei, Wei T. Yang, Lumarie Santiago, Marion E. Scoggins, Rosalind P. Candelaria, Alastair M. Thompson, Gary J. Whitman, et al. 2021. “Early Ultrasound Evaluation Identifies Excellent Responders to Neoadjuvant Systemic Therapy among Patients with Triple‐negative Breast Cancer.” Cancer 127 (April): 2880–87. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....43b248fd85f93cc33db8890223ada0e8&authtype=sso&custid=ns315887.